A clinicalm trial to study the effects of a herbal drug Dawa-e-Musakkin in patients with anxity and Tension

Phase 2

Completed

• Conditions: Generalized Anxiety Disorder

• Registration Number: CTRI/2009/091/000761
• Lead Sponsor: Hamdard National Foundation, New Delhi

Brief Summary

Tis study is a randomized , double blind parallel group trial comparing tthe efficacy of a herbal drug Dawa-e-Musakkin 2 gram daily with Placebo 2 gram daily in 50 patients of Generalized Anxiety Disorder for 3 months.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-01-03
• Last Update Posted: 2012-01-20

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

?Age and Sex- 18-60 years, either sex?Patients diagnosed as cases of generalized anxiety disorder according to DSM-IV diagnostic Criteria.

Exclusion Criteria

?Pregnancy or lactation?Women patients above 45 years of age( Post menopausal women)?Patients with past or current history of cigarette smoking, drug or alcohol abuse.?Patients of hyperthyroidism or hypothyroidism.?Patients with a history of hypoglycemic episodes.?Any cardiovascular /or chest diseases.

Study & Design

• Study Type: Not specified
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in mean Hamilton Anxiety Rating score	4,8,12 week

Secondary Outcome Measures

Name	Time	Method
Improvement in performance	3 months

Trial Locations

Locations (1)

Clinical Research Unit, Majeedia Hospital; 🇮🇳 Delhi, DELHI, India

Clinical Research Unit, Majeedia Hospital

🇮🇳Delhi, DELHI, India

Dr. Yasmeen Shamsi

Principal investigator

011-26059692

yasmeen.ijum@gmail.com